Testing the blood of early stage breast cancer patients for circulating tumor cells (CTCs) may predict their chance for recurrence and survival, and help identify which ones may need additional treatment, according to a new study published on Wednesday. However, the findings need to be confirmed by larger trials before such a method can be considered for clinical use...
More...